Studies on the purification and characterization of human factor VIII

Factor VIII (antihemophilic globulin) has been prepared from Hyland method IV AHG and cryoprecipitate using limited chymotryptic digestion followed by Sepharose gel filtration. The activity of factor VIII is unaffected by the digestion procedure, while fibrinogen in converted to large noncoagulable fragments. The purified factor VIII has been found to be a macromolecular glycoprotein with a major subunit of 240,000, as shown by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. Carbohydrate analysis of factor VIII gave values of 1% sialic acid, 2.8% hexosamine, and 1-2% hexose (mannose, galactose, and fucose). The lipid content was found to be less than 5% of the protein content, and included no detectable phospholipid. The amino acid content is also reported. Immunoelectrophoretic analysis using rabbit antibody to purified factor VIII produced a single precipitin line. The chymotrypsin digestion step facilitates the preparation of factor VIII by reducing the viscosity of fibrinogen in the crude starting material, thereby increasing fivefold the quantity of material which can be processed at one time. It also improves markedly the resolution between factor VIII and fibrinogen on gel filtration.

[1]  C. Tanford,et al.  Polypeptide chains from human red blood cell membranes. , 1971, The Journal of biological chemistry.

[2]  A. Davison,et al.  Human factor VIII (antihemophilic factor): activa- tion and inactivation by phospholipases. , 1971, The Journal of laboratory and clinical medicine.

[3]  A. Davison,et al.  Isolation and some chemical properties of human factor VIII (antihemophilic factor). , 1971, The Journal of laboratory and clinical medicine.

[4]  D. Green.  A simple method for the purification of factor VIII (antihemophilic factor) employing snake venom. , 1971, The Journal of laboratory and clinical medicine.

[5]  T. Zimmerman,et al.  Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor. , 1971, The Journal of clinical investigation.

[6]  J. V. van Mourik,et al.  Purification of human antihemophilic factor (factor VIII) by gel chromatography. , 1970, Biochimica et biophysica acta.

[7]  W. Dreyer,et al.  Isolation of the fundamental polypeptide subunits of biological membranes. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[8]  H. Weiss,et al.  Molecular Forms of Antihaemophilic Globulin in Plasma, Cryoprecipitate and after Thrombin Activation , 1970, British journal of haematology.

[9]  M. Paulssen,et al.  Purification of the Antihemophilic Factor by Gel Filtration on Agarose , 1969, Thrombosis and Haemostasis.

[10]  O. Ratnoff,et al.  Studies on the purification of antihemophilic factor (factor VIII). II. Separation of partially purified antihemophilic factor by gel filtration of plasma. , 1969, The Journal of clinical investigation.

[11]  J. Niemetz,et al.  Activated Coagulation Factors: In‐Vivo and in‐Vitro Studies , 1969, British journal of haematology.

[12]  M. A. León,et al.  Studies on the purification of antihemophilic factor (factor 8. I. Precipitation of antihemophilic factor by concanavalin A. , 1969, The Journal of clinical investigation.

[13]  M. Blombäck,et al.  Fractions rich in factor VIII. , 1968, Bibliotheca haematologica.

[14]  S. Sherry,et al.  Human fibrinogen of relatively high solubility. Comparative biophysical, biochemical, and biological studies with fibrinogen of lower solubility. , 1967, Biochemistry.

[15]  J V Maizel,et al.  Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels. , 1967, Biochemical and biophysical research communications.

[16]  C. Abildgaard,et al.  A semiautomatic one-stage factor 8 assay with a commercially prepared standard. , 1967, The Journal of laboratory and clinical medicine.

[17]  Brinkhous Km,et al.  Human antihemophilic factor (AHF) purification: A comparison of two procedures. , 1966 .

[18]  E. Eylar.  On the biological role of glycoproteins. , 1966, Journal of theoretical biology.

[19]  E. Hershgold,et al.  The potent antihemophilic globulin concentrate derived from a cold insoluble fraction of human plasma: characterization and further data on preparation and clinical trial. , 1966, The Journal of laboratory and clinical medicine.

[20]  C. Rizza,et al.  Separation of Factor VIII (Antihaemophilic Factor) Activity from Fibrinogen by Means of a Snake Venom , 1965, Nature.

[21]  R. G. Macfarlane,et al.  Thrombin and the Interaction of Factors VIII and IX , 1965 .

[22]  K. Brinkhous,et al.  Purification of Antihemophilic Factor (Factor VIII) by Amino Acid Precipitation* , 1964, Thrombosis and Haemostasis.

[23]  J. Finlayson,et al.  SUBFRACTIONS OF HUMAN FIBRINOGEN; PREPARATION AND ANALYSIS. , 1963, The Journal of laboratory and clinical medicine.

[24]  S. Rapaport,et al.  The importance of activation of antihemophilic globulin and proaccelerin by traces of thrombin in the generation of intrinsic prothrombinase activity. , 1963, Blood.

[25]  L. Warren,et al.  The thiobarbituric acid assay of sialic acids. , 1959, The Journal of biological chemistry.

[26]  J. Pool,et al.  Assay of Plasma Antihaemophilic Globulin (AHG) * , 1959, British journal of haematology.

[27]  T. Reynolds,et al.  Isolation of Mucic Acid from Fruits , 1954, Nature.

[28]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[29]  E J COHN,et al.  Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. , 1946, Journal of the American Chemical Society.